Skip to main content
Equibles

PRUDENTIAL FINANCIAL INC

Position in DSGN — Design Therapeutics, Inc.

CIK 1137774 NEWARK, NJ
Back to DSGN Full portfolio

Position in DSGN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$3,243,739
+$2,756,321 QoQ
Shares Held
224,170
+389.3% QoQ
Ownership
0.358%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 136 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRUDENTIAL FINANCIAL INC holds $557,787,882 across 190 Biotechnology names. DSGN ranks #39 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 130,659 $81,471,112
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 133,294 $66,211,127
3 BMRN
Biomarin Pharmaceutical Inc
 392,811 $22,476,644
4 INCY
Incyte Corp
 191,312 $21,687,128
5 CYTK
Cytokinetics Inc
 214,535 $18,276,236
6 LGND
Ligand Pharmaceuticals Inc
 54,623 $17,265,784
7 PTCT
Ptc Therapeutics, Inc.
 185,820 $15,157,337
8 MRVI
Maravai Lifesciences Holdings, Inc.
 2,152,154 $13,429,440

All Filings in DSGN

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,243,739 224,170
2026-03-31 $487,418 45,810
2025-12-31 $400,619 42,710
2025-09-30 $337,532 44,825
2025-06-30 $195,207 57,925
2025-03-31 $217,723 56,405
2024-12-31 $347,463 56,315
2024-09-30 $318,038 59,115
2024-06-30 $211,770 63,215
2024-03-31 $188,664 46,815
2023-12-31 $48,799 18,415
2023-09-30 $43,459 18,415
2023-06-30 $165,154 26,215